Deutsches Herzzentrum Muenchen Des Freistaates Bayern Klinik An Der Technischen Universitaet Muenchen — Clinical Trial Site

26 Registered trials

10 Currently recruiting

Organisation

Deutsches Herzzentrum Muenchen Des Freistaates Bayern Klinik An Der Technischen Universitaet Muenchen

Location

Munich, Germany

Identifier

ORG-100009127

Address

Lazarettstrasse 36, Neuhausen-Nymphenburg, 80636, Germany

Departments

#1400: Department of Cardiovascular Diseases
#3430: Deutsches Herzzentrum München
2001: Deutsches Herzzentrum München
3430: Deutsches Herzzentrum München
Cardiology
Cardiovascular Diseases
Cardiovascular Surgery
Department of Cardiovascular Surgery
Department of Congenital Heart Defects and Pediatric Cardiology
Deutsches Herzzentrum
Deutsches Herzzentrum Muenchen des Freistaates Bayern
Deutsches Herzzentum München
Klinik für Herz- Kreislaufkrankheiten
Klinik für Herz- und Gefäßchirurgie
Klinik für Herz- und Kreislauferkrankungen
Klinik für Herz- und Kreislauferkrankungen und für angeborene Herzfehler und Kinderkardiologie
Klinik für Herz-& Kreislauferkrankungen
Klinik für Herz-Kreislaufkrankheit
Klinik für Herz-und Kreislauferkrankungen
N/A
NA
TUM University Hospital German Heart Center, Department of Cardiovascular Surgery

Clinical trials at this site (26)

Search interface

An open-label extension (OLE) trial to evaluate long-term safety and tolerability of pelacarsen (TQJ230) Recruiting

2024-519870-38-00 Atherosclerotic cardiovascular disease (ASCVD) 5 2026-05-11
CLEOPATTRA: A research study to look at the effects of treatment with a medicine called coramitug (NNC6019-0001) in people with heart failur… Recruiting

2024-518899-31-00 Variant or wild-type transthyretin (TTR) amyloid cardio 5 2025-12-19
OCEAN(a)-CCTA - Olpasiran trials of Cardiovascular Events And LipoproteiN(a) reduction -Coronary Computed Tomography Angiography trial Recruiting

2025-521117-88-00 Cardiovascular Disease 5 2026-03-11
Multi-Center, Open Label Gene Therapy Study of RP-A501 in Male Patients with Danon Disease Recruiting

2023-506480-34-00 Danon Disease 4 2026-02-26
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants with Atherosclerotic Cardiovascular Disease and … Recruiting

2024-516652-18-00 Atherosclerotic cardiovascular disease (ASCVD) and obes 5 2025-10-10
Reduction of occurence of Acute Kidney Injury through administration of angiotensin II versus Noradrenaline Recruiting

2024-517771-21-00 Acute kidney injury 11 2025-03-31
PROTamine Application in patients underGOing tRAnScatheter aortic valve replacement (PROTAGORAS) Recruiting

2024-512024-10-01 Adult patients with severe aortic stenosis scheduled fo 5 2025-03-28
The One-Month DAPT with Ticagrelor In CABG PatieNts Trial (ODIN) Recruiting

2023-506613-22-00 coronary artery disease 5 2024-09-25
A randomized double-blind, placebo-controlled, multicenter trial assessing the impact of lipoprotein(a) lowering with pelacarsen (TQJ230) on… Recruiting

2022-502135-19-00 Calcific Aortic Valve Stenosis 4 2024-07-18
Preventing formation of blood clots due to atrial fibrillation, a cardiac arrhythmia that first occurred after coronary bypass surgery, with… Recruiting

2024-515924-35-00 New-Onset Post-Operative Atrial Fibrillation after CABG 6 2023-01-16
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a) ( MOVE-Lp(a) ) Ended

2025-521067-13-00 Atherosclerotic Cardiovascular Disease (ASCVD) 5 2026-04-24
A Study to Find Out How Safe and Well AZD0780 Works for Adults with High 'Bad' Cholesterol and with Heart- Stroke or Vascular Disease or at … Ended

2025-520521-21-00 Hyperlipidemia 5 2025-09-02
A Study of Lepodisiran (LY3819469) in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a) Ended

2023-509190-23-00 Atherosclerotic Cardiovascular Disease Elevated lp(a) 5 2024-09-03
A Study of Mavacamten in Adolescent Participants with Symptomatic Obstructive Hypertrophic Cardiomyopathy Ended

2023-505650-17-00 Symptomatic Obstructive Hypertrophic Cardiomyopathy 5 2024-08-27
ARTEMIS - A research study to look at how ziltivekimab works compared to placebo in people who have had a heart attack Ended

2023-506876-28-00 The medical condition we are investigating is type 1 AM 5 2024-08-01
OCEAN(a)-Outcomes – Olpasiran trials of Cardiovascular Events And LipoproteiN(a) reduction – Outcomes trial Ended

2022-501608-85-00 Cardiovascular disease (atherosclerotic cardiovascular 5 2023-05-09
A multicenter trial assessing the impact of lipoprotein (a) lowering with pelacarsen (TQJ230) on major cardiovascular events in patients wit… Ended

2023-508292-37-00 Cardiovascular Disease 5 2020-03-06
A prospective randomized, single-blind, multicenter phase II study comparing two methods of cardioplegia in cardiac surgery due to congenita… Halted

2024-511517-38-00 congenital heart malformation inchildren 4 2024-11-05
A phase 2b dose finding study of RMC-035 in participants undergoing open-chest cardiac surgery Ended

2024-510658-28-00 Loss of renal function following cardiac surgery 4 2024-09-24
A randomized, placebo-controlled, parallel-group, investigator- and participant-blinded Phase 2a study to investigate the efficacy, safety, … Ended

2023-506741-34-00 Atherosclerotic cardiovascular disease 4 2024-02-16
Ilofotase alfa for prevention of renal damage after cardiac surgery Ended

2023-505859-45-00 Risk for renal damage following open heart surgery 4 2023-12-19
A Randomized, Double-blind, Placebo-controlled Clinical Study to Evaluate Mavacamten in Adults with Cardiomyopathy Ended

2023-506352-24-00 Non-obstructive Hypertrophic Cardiomyopathy 5 2023-04-13
Effect of antifibrotic therapy on regression of myocardial fibrosis after transcatheter aortic valve implantation (TAVI) in aortic stenosis … Ended

2024-510869-42-00 aortic stenosis patients with high fibrotic burden 4 2022-02-28
Escalated single Platelet Inhibition for one month plus Direct oral anticoagulation in patients with Atrial fibrillation and acUte coRonary … Ended

2024-512727-36-00 Patients with atrial fibrillation and ST-segment elevat 6 2021-12-21